ZA972340B - Use of antiarrhythmic compounds in the prevention of post-infarction mortality - Google Patents
Use of antiarrhythmic compounds in the prevention of post-infarction mortalityInfo
- Publication number
- ZA972340B ZA972340B ZA972340A ZA972340A ZA972340B ZA 972340 B ZA972340 B ZA 972340B ZA 972340 A ZA972340 A ZA 972340A ZA 972340 A ZA972340 A ZA 972340A ZA 972340 B ZA972340 B ZA 972340B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- post
- antiarrhythmic compounds
- infarction mortality
- infarction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9603357A FR2746013B1 (fr) | 1996-03-18 | 1996-03-18 | Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA972340B true ZA972340B (en) | 1998-09-18 |
Family
ID=9490276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA972340A ZA972340B (en) | 1996-03-18 | 1997-03-18 | Use of antiarrhythmic compounds in the prevention of post-infarction mortality |
Country Status (14)
Country | Link |
---|---|
US (1) | US5985915A (ja) |
EP (1) | EP0796617A1 (ja) |
JP (1) | JP3253092B2 (ja) |
KR (1) | KR20000064760A (ja) |
CN (1) | CN1213965A (ja) |
AU (1) | AU719358B2 (ja) |
CA (1) | CA2249481A1 (ja) |
FR (1) | FR2746013B1 (ja) |
HU (1) | HUP9902580A3 (ja) |
IL (1) | IL125980A0 (ja) |
NO (1) | NO984299L (ja) |
NZ (1) | NZ331931A (ja) |
WO (1) | WO1997034597A1 (ja) |
ZA (1) | ZA972340B (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785995A (en) * | 1997-04-11 | 1998-07-28 | Upsher-Smith Laboratories, Inc. | Pharmaceutical tablet of amiodarone salt |
FR2764800B1 (fr) * | 1997-06-23 | 1999-09-10 | Sanofi Sa | Composition pharmaceutique solide contenant des derives de benzofuranne |
US6583198B2 (en) | 1997-11-28 | 2003-06-24 | Hitachi Chemical Company, Ltd. | Photo curable resin composition and photosensitive element |
DE19820151A1 (de) * | 1998-05-06 | 1999-11-11 | Hexal Ag | Transdermales therapeutisches System zur Anwendung von Candesartan |
BR9912145A (pt) * | 1998-07-20 | 2001-09-25 | Smithkline Beecham Corp | Formulações bioaperfeiçoadas contendo eprosartan em forma de dosagem sólida oral |
DK1117409T3 (da) | 1998-09-10 | 2005-05-30 | Aventis Pharma Gmbh | Benzensulfonyl(thio)ureaforbindelser i kombination med beta-blokkere til behandling af dysfunktioner i det autonome nervesystem |
AU1157500A (en) * | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof |
CA2363792C (en) | 1999-02-19 | 2009-10-27 | Takeda Chemical Industries, Ltd. | Percutaneous absorption preparation of compound having angiotensin ii antagonistic activity |
EA003052B1 (ru) * | 1999-07-27 | 2002-12-26 | Балканфарма Холдинг АД | Антиаритмическое лекарственное средство |
FR2817750B1 (fr) * | 2000-12-11 | 2003-02-21 | Sanofi Synthelabo | Composition pharmaceutique de dronedarone pour administration parenterale |
US7413751B2 (en) * | 2001-10-25 | 2008-08-19 | Depomed, Inc. | Methods of treatment using a gastric retained losartan dosage |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
EP1652508B1 (en) * | 2003-07-31 | 2013-12-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
DE602005025755D1 (de) | 2004-06-04 | 2011-02-17 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
GB0719180D0 (en) | 2007-10-02 | 2007-11-14 | Cambrex Karlskoga Ab | New process |
FR2930148A1 (fr) * | 2008-04-17 | 2009-10-23 | Sanofi Aventis Sa | Utilisation de la dronedarone pour la preparation d'un medicament destine a la prevention de l'hospitalisation cardiovasculaire ou de la mortalite |
FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
EP2280701A2 (en) | 2008-04-17 | 2011-02-09 | Sanofi-Aventis | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
WO2011135581A2 (en) * | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Pharmaceutical compositions of dronedarone |
US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
EP2431033A1 (en) | 2010-08-10 | 2012-03-21 | Sanofi | Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation |
WO2012020377A1 (en) | 2010-08-11 | 2012-02-16 | Sanofi | Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation |
US20130116586A1 (en) | 2011-07-07 | 2013-05-09 | Sanofi | Use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of atrial fibrillation |
WO2013024411A1 (en) | 2011-08-12 | 2013-02-21 | Lupin Limited | Co-milled formulation of dronedarone |
CN102526469B (zh) * | 2012-02-16 | 2013-07-10 | 罗群 | 一种用于心梗后康复的复方药物及其制备方法 |
EP2674158B9 (en) * | 2012-06-14 | 2015-11-18 | Szegedi Tudományegyetem | Treatment and prevention of cardiac arrhythmias |
CN104414970A (zh) * | 2013-09-10 | 2015-03-18 | 成都力思特制药股份有限公司 | 一种盐酸胺碘酮注射液及其制备方法 |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN107753439A (zh) * | 2016-08-22 | 2018-03-06 | 黑龙江迪龙制药有限公司 | 一种注射用盐酸胺碘酮及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2550091B1 (fr) * | 1983-08-02 | 1986-05-23 | Sanofi Sa | Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne |
US5252600A (en) * | 1988-01-25 | 1993-10-12 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
FR2626176A1 (fr) * | 1988-01-25 | 1989-07-28 | Baligadoo Soorianarain | Preparations medicamenteuses cardioprotectrices comprenant l'amiodarone un derive nitre, et facultativement un beta-bloqueur |
FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
AU7854094A (en) * | 1993-10-04 | 1995-05-01 | Handforth Investments Ltd. | Use of amiodarone for the treatment of heart failure |
-
1996
- 1996-03-18 FR FR9603357A patent/FR2746013B1/fr not_active Expired - Fee Related
-
1997
- 1997-03-17 HU HU9902580A patent/HUP9902580A3/hu unknown
- 1997-03-17 WO PCT/FR1997/000474 patent/WO1997034597A1/fr not_active Application Discontinuation
- 1997-03-17 KR KR1019980707523A patent/KR20000064760A/ko active IP Right Grant
- 1997-03-17 NZ NZ331931A patent/NZ331931A/xx unknown
- 1997-03-17 US US08/819,863 patent/US5985915A/en not_active Expired - Fee Related
- 1997-03-17 JP JP53320197A patent/JP3253092B2/ja not_active Expired - Fee Related
- 1997-03-17 EP EP97400593A patent/EP0796617A1/fr not_active Withdrawn
- 1997-03-17 AU AU22962/97A patent/AU719358B2/en not_active Ceased
- 1997-03-17 CN CN97193158A patent/CN1213965A/zh active Pending
- 1997-03-17 IL IL12598097A patent/IL125980A0/xx unknown
- 1997-03-17 CA CA002249481A patent/CA2249481A1/fr not_active Abandoned
- 1997-03-18 ZA ZA972340A patent/ZA972340B/xx unknown
-
1998
- 1998-09-17 NO NO984299A patent/NO984299L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9902580A2 (hu) | 2001-05-28 |
CA2249481A1 (fr) | 1997-09-25 |
US5985915A (en) | 1999-11-16 |
FR2746013A1 (fr) | 1997-09-19 |
EP0796617A1 (fr) | 1997-09-24 |
JPH11507063A (ja) | 1999-06-22 |
KR20000064760A (ko) | 2000-11-06 |
CN1213965A (zh) | 1999-04-14 |
NO984299L (no) | 1998-11-17 |
FR2746013B1 (fr) | 1998-05-29 |
WO1997034597A1 (fr) | 1997-09-25 |
HUP9902580A3 (en) | 2001-08-28 |
NO984299D0 (no) | 1998-09-17 |
AU2296297A (en) | 1997-10-10 |
NZ331931A (en) | 2000-08-25 |
AU719358B2 (en) | 2000-05-04 |
JP3253092B2 (ja) | 2002-02-04 |
IL125980A0 (en) | 1999-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA972340B (en) | Use of antiarrhythmic compounds in the prevention of post-infarction mortality | |
EP0730454A4 (en) | ANTIARRHYTHMIC BENZODIAZEPINES | |
IL133603A0 (en) | Triazole compounds and the use thereof as dopamine-d3-ligands | |
ZA97171B (en) | Novel use | |
IL125319A0 (en) | N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds | |
EP0730456A4 (en) | ANTIARRHYTHMIC BENZODIAZEPINES | |
GB9702354D0 (en) | Compounds and their use | |
GB9309598D0 (en) | Cryoprobe | |
EP0730455A4 (en) | ANTIARRHYTHMIC BENZODIAZEPINE | |
GB9606016D0 (en) | Novel use | |
GB9621990D0 (en) | Use | |
GB9311423D0 (en) | New use | |
GB9409054D0 (en) | Pontoon structures | |
HK1025089A1 (en) | Nitro-benzamide useful as antiarrhythmic agent | |
GB9310880D0 (en) | Towel | |
IL120177A0 (en) | Antiarrhythmic agents and their preparation | |
GB9611192D0 (en) | Use | |
GB9309179D0 (en) | New use | |
KR200157515Y1 (en) | Multi-purpose keeping structure | |
EG20431A (en) | The dynamic bruce | |
HU9601372D0 (en) | Antiarrhythmic benzodiazepines | |
GB9626360D0 (en) | Use | |
GB9409558D0 (en) | Marine structures | |
GB9614575D0 (en) | Random selection of numbers | |
HRP931242A2 (en) | Multiple use diaper-panties |